SAMHD1 degradation enhances active suppression of dendritic cell maturation by HIV-1

Journal of Immunology

Volumn 194, Issue 9, 2015, Pages 4431-4437

  Hertoghs, Nina ^a   Van Der Aar, Angelic M G ^a   Setiawan, Laurentia C ^a   Kootstra, Neeltje A ^a   Gringhuis, Sonja I ^a   Geijtenbeek, Teunis B H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; MEMBRANE PROTEIN; PROTEIN SAMHD1; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; SAMHD1 PROTEIN, HUMAN; VIRUS PROTEIN; VPX PROTEIN, SIMIAN IMMUNODEFICIENCY VIRUS;

ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DENSITY GRADIENT CENTRIFUGATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOREACTIVITY; IMMUNOSURVEILLANCE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; CYTOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION; VIROLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOMODULATION; MONOMERIC GTP-BINDING PROTEINS; PROTEOLYSIS; REVERSE TRANSCRIPTION; TOLL-LIKE RECEPTORS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION;

EID: 84928473395     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403016     Document Type: Article

References (73)

1. WHO. 2011. UNAIDS 2010: Getting to zero. Available at: http://www.unaids.org/sites/default/files/sub-landing/files/JC2034-UNAIDS-Strategy-en.pdf. Accessed: February 28, 2014.
2. Che, K. F., R. L. Sabado, E. M. Shankar, V. Tjomsland, D. Messmer, N. Bhardwaj, J. D. Lifson, and M. Larsson. 2010. HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells. Eur. J. Immunol. 40: 2248-2258.
3. Luban, J. 2012. Innate immune sensing of HIV-1 by dendritic cells. Cell Host Microbe 12: 408-418.
4. Trautmann, L., L. Janbazian, N. Chomont, E. A. Said, S. Gimmig, B. Bessette, M.-R. Boulassel, E. Delwart, H. Sepulveda, R. S. Balderas, et al. 2006. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
5. Wherry, E. J., S. J. Ha, S. M. Kaech, W. N. Haining, S. Sarkar, V. Kalia, S. Subramaniam, J. N. Blattman, D. L. Barber, and R. Ahmed. 2007. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 670-684.
6. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
7. Brainard, D. M., E. Seung, N. Frahm, A. Cariappa, C. C. Bailey, W. K. Hart H.-S. Shin, S. F. Brooks, H. L. Knight, Q. Eichbaum, et al. 2009. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J. Virol. 83: 7305-7321.
8. Smed-Sörensen, A., K. Loré, L. Walther-Jallow, J. Andersson, and A. L. Spetz. 2004. HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood 104: 2810-2817.
9. Miller, E., and N. Bhardwaj. 2013. Dendritic cell dysregulation during HIV-1 infection. Immunol. Rev. 254: 170-189.
10. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
11. Altfeld, M., L. Fadda, D. Frleta, and N. Bhardwaj. 2011. DCs and NK cells: critical effectors in the immune response to HIV-1. Nat. Rev. Immunol. 11: 176-186.
12. Kratky, W., C. Reis e Sousa, A. Oxenius, and R. Spörri. 2011. Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination. Proc. Natl. Acad. Sci. USA 108: 17414-17419.
13. Spörri, R., and C. Reis e Sousa. 2005. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 6: 163-170.
14. Ay, E. S. S. 2006. Dendritic cells in a mature age. Nat Rev Immunol. 6: 476-483.
15. Hou, B., B. Reizis, and A. L. DeFranco. 2008. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms. Immunity 29: 272-282.
16. Gringhuis, S. I., M. van der Vlist, L. M. van den Berg, J. den Dunnen, M. Litjens, and T. B. Geijtenbeek. 2010. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat. Immunol. 11: 419-426.
17. Geijtenbeek, T. B., D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. KewalRamani, D. R. Littman, et al. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587-597.
18. Pertel, T., S. Hausmann, D. Morger, S. Züger, J. Guerra, J. Lascano, C. Reinhard, F. A. Santoni, P. D. Uchil, L. Chatel, et al. 2011. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472: 361-365.
19. Cao, W., L. Bover, M. Cho, X. Wen, S. Hanabuchi, M. Bao, D. B. Rosen, Y.-H. Wang, J. L. Shaw, Q. Du, et al. 2009. Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J. Exp. Med. 206: 1603-1614.
20. Lahaye, X., T. Satoh, M. Gentili, S. Cerboni, C. Conrad, I. Hurbain, A. El Marjou, C. Lacabaratz, J.-D. Lelièvre, and N. Manel. 2013. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 39: 1132-1142.
21. Unterholzner, L., S. E. Keating, M. Baran, K. A. Horan, S. B. Jensen, S. Sharma, C. M. Sirois, T. Jin, E. Latz, T. S. Xiao, et al. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11: 997-1004.
22. Cocka, L. J., and P. Bates. 2012. Identification of alternatively translated tetherin isoforms with differing antiviral and signaling activities. PLoS Path. 8: e1002931. Available at: http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1002931.
23. Evans, D. T., R. Serra-Moreno, R. K. Singh, and J. C. Guatelli. 2010. BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol. 18: 388-396.
24. Smed-Sörensen, A., K. Loré, J. Vasudevan, M. K. Louder, J. Andersson, J. R. Mascola, A.-L. Spetz, and R. A. Koup. 2005. Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J. Virol. 79: 8861-8869.
25. Nobile, C., C. Petit, A. Moris, K. Skrabal, J.-P. Abastado, F. Mammano, and O. Schwartz. 2005. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J. Virol. 79: 5386-5399.
26. Granelli-Piperno, A., A. Golebiowska, C. Trumpfheller, F. P. Siegal, and R. M. Steinman. 2004. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc. Natl. Acad. Sci. USA 101: 7669-7674.
27. Muthumani, K., D. S. Hwang, A. Y. Choo, S. Mayilvahanan, N. S. Dayes, K. P. Thieu, and D. B. Weiner. 2005. HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro. Int. Immunol. 17: 103-116.
28. Rodriguez-Plata, M. T., A. Urrutia, S. Cardinaud, M. J. Buzón, N. Izquierdo-Useros, J. G. Prado, M. C. Puertas, I. Erkizia, P.-G. Coulon, S. Cedeño, et al. 2012. HIV-1 capture and antigen presentation by dendritic cells: enhanced viral capture does not correlate with better T cell activation. J. Immunol. 188: 6036-6045.
29. Manel, N., B. Hogstad, Y. Wang, D. E. Levy, D. Unutmaz, and D. R. Littman. 2010. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467: 214-217.
30. Laguette, N., B. Sobhian, N. Casartelli, M. Ringeard, C. Chable-Bessia, E. Ségéral, A. Yatim, S. Emiliani, O. Schwartz, and M. Benkirane. 2011. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474: 654-657.
31. Ayinde, D., N. Casartelli, and O. Schwartz. 2012. Restricting HIV the SAMHD1 way: through nucleotide starvation. Nat. Rev. Microbiol. 10: 675-680.
32. St Gelais, C., and L.Wu. 2011. SAMHD1: a new insight into HIV-1 restriction in myeloid cells. Retrovirology 8: 55.
33. Goldstone, D. C., V. Ennis-Adeniran, J. J. Hedden, H. C. T. Groom, G. I. Rice, E. Christodoulou, P. A. Walker, G. Kelly, L. F. Haire, M. W. Yap, et al. 2011. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480: 379-382.
34. Lahouassa, H., W. Daddacha, H. Hofmann, D. Ayinde, E. C. Logue, L. Dragin, N. Bloch, C. Maudet, M. Bertrand, T. Gramberg, et al. 2012. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 13: 223-228.
35. Ryoo, J., J. Choi, C. Oh, S. Kim, M. Seo, S.-Y. Kim, D. Seo, J. Kim, T. E. White, A. Brandariz-Nuñez, et al. 2014. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat. Med. 20: 936-941.
36. Geijtenbeek, T. B., R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, G. J. Adema, Y. van Kooyk, and C. G. Figdor. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100: 575-585.
37. de Witte, L., A. Nabatov, M. Pion, D. Fluitsma, M. A. W. P. de Jong, T. de Gruijl, V. Piguet, Y. van Kooyk, and T. B. Geijtenbeek. 2007. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat. Med. 13: 367-371.
38. de Jong, M. A. W. P., L. de Witte, M. J. Oudhoff, S. I. Gringhuis, P. Gallay, and T. B. H. Geijtenbeek. 2008. TNF-α and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J. Clin. Invest. 118: 3440-3452.
39. Gallay, P., T. Hope, D. Chin, and D. Trono. 1997. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. USA 94: 9825-9830.
40. Chatterji, U., M. D. Bobardt, R. Stanfield, R. G. Ptak, L. A. Pallansch, P. A. Ward, M. J. Jones, C. A. Stoddart, P. Scalfaro, J. M. Dumont, et al. 2005. Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells. J. Biol. Chem. 280: 40293-40300.
41. de Jong, E. C., P. L. Vieira, P. Kalinski, J. H. N. Schuitemaker, Y. Tanaka, E. A. Wierenga, M. Yazdanbakhsh, and M. L. Kapsenberg. 2002. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J. Immunol. 168: 1704-1709.
42. Gringhuis, S. I., J. den Dunnen, M. Litjens, M. van der Vlist, B. Wevers, S. C. M. Bruijns, and T. B. Geijtenbeek. 2009. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat. Immunol. 10: 203-213.
43. García-Vallejo, J. J., B. Van Het Hof, J. Robben, J. A. E. Van Wijk, I. Van Die, D. H. Joziasse, and W. Van Dijk. 2004. Approach for defining endogenous reference genes in gene expression experiments. Anal. Biochem. 329: 293-299.
44. Manel, N., and D. R. Littman. 2011. Hiding in plain sight: how HIV evades innate immune responses. Cell 147: 271-274.
45. Hrecka, K., C. Hao, M. Gierszewska, S. K. Swanson, M. Kesik-Brodacka, S. Srivastava, L. Florens, M. P. Washburn, and J. Skowronski. 2011. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474: 658-661.
46. Aiken, C. 1997. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71: 5871-5877.
47. Granelli-Piperno, A., V. Finkel, E. Delgado, and R. M. Steinman. 1999. Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells. Curr. Biol. 9: 21-29.
48. Donaghy, H., B. Gazzard, F. Gotch, and S. Patterson. 2003. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 101: 4505-4511.
49. Mohanram, V., A. E. Sköld, S. M. Bächle, S. K. Pathak, and A. L. Spetz. 2013. IFN-α induces APOBEC3G, F, and A in immature dendritic cells and limits HIV-1 spread to CD4+ T cells. J. Immunol. 190: 3346-3353.
50. Mohanram, V., U. Johansson, A. E. Sköld, J. Fink, S. Kumar Pathak, B. Mäkitalo, L. Walther-Jallow, and A. L. Spetz. 2011. Exposure to apoptotic activated CD4+ T cells induces maturation and APOBEC3G-mediated inhibition of HIV-1 infection in dendritic cells. PLoS ONE 6: e21171. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0021171.
51. Cameron, P. U., P. S. Freudenthal, J. M. Barker, S. Gezelter, K. Inaba, and R. M. Steinman. 1992. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science 257: 383-387.
52. Fonteneau, J.-F., M. Larsson, A.-S. Beignon, K. McKenna, I. Dasilva, A. Amara, Y. J. Liu, J. D. Lifson, D. R. Littman, and N. Bhardwaj. 2004. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J. Virol. 78: 5223-5232.
53. Hladik, F., P. Sakchalathorn, L. Ballweber, G. Lentz, M. Fialkow, D. Eschenbach, and M. J. McElrath. 2007. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26: 257-270.
54. Lichtner, M., C. Marañón, P.-O. Vidalain, O. Azocar, D. Hanau, P. Lebon, M. Burgard, C. Rouzioux, V. Vullo, H. Yagita, et al. 2004. HIV type 1-infected dendritic cells induce apoptotic death in infected and uninfected primary CD4 T lymphocytes. AIDS Res. Hum. Retroviruses 20: 175-182.
55. Rasaiyaah, J., C. P. Tan, A. J. Fletcher, A. J. Price, C. Blondeau, L. Hilditch, D. A. Jacques, D. L. Selwood, L. C. James, M. Noursadeghi, and G. J. Towers. 2013. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 503: 402-405.
56. Sunseri, N., M. O'Brien, N. Bhardwaj, and N. R. Landau. 2011. Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells. J. Virol. 85: 6263-6274.
57. Su, B., M. E. Biedma, A. Lederle, M. Peressin, M. Lambotin, A. Proust, T. Decoville, S. Schmidt, G. Laumond, and C. Moog. 2014. Dendritic cell-lymphocyte cross talk downregulates host restriction factor SAMHD1 and stimulates HIV-1 replication in dendritic cells. J. Virol. 88: 5109-5121.
58. Planès, R., L. BenMohamed, K. Leghmari, P. Delobel, J. Izopet, and E. Bahraoui. 2014. HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through TNF-α and TLR4 mediated mechanisms. J. Virol. 88: 6672-6689.
59. Gupta, S., R. Boppana, G. C. Mishra, B. Saha, and D. Mitra. 2008. HIV-1 Tat suppresses gp120-specific T cell response in IL-10-dependent manner. J. Immunol. 180: 79-88.
60. Planès, R., and E. Bahraoui. 2013. HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation. PLoS ONE 8: e74551. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0074551.
61. Herath, S., A. Benlahrech, T. Papagatsias, T. Athanasopoulos, Z. Bouzeboudjen, C. Hervouet, L. Klavinskis, A. Meiser, P. Kelleher, G. Dickson, and S. Patterson. 2014. Fusion of ubiquitin to HIV gag impairs human monocyte-derived dendritic cell maturation and reduces ability to induce gag T cell responses. PLoS ONE 9: e88327. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0088327.
62. Huang, X.-L., Z. Fan, L. Borowski, and C. R. Rinaldo. 2008. Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8(+) T cell immunity. J. Leukoc. Biol. 83: 1530-1540.
63. Harman, A. N., J. Wilkinson, C. R. Bye, L. Bosnjak, J. L. Stern, M. Nicholle, J. Lai, and A. L. Cunningham. 2006. HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. J. Immunol. 177: 7103-7113.
64. Mercier, S. K., H. Donaghy, R. A. Botting, S. G. Turville, A. N. Harman, N. Nasr, H. Ji, U. Kusebauch, L. Mendoza, D. Shteynberg, et al. 2013. The microvesicle component of HIV-1 inocula modulates dendritic cell infection and maturation and enhances adhesion to and activation of T lymphocytes. PLoS Pathog. 9: e1003700. Available at: http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1003700.
65. Yonkers, N. L., B. Rodriguez, R. Asaad, M. M. Lederman, and D. D. Anthony. 2011. Systemic immune activation in HIV infection is associated with decreased MDC responsiveness to TLR ligand and inability to activate naive CD4 T-cells. PLoS ONE 6: e23884. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0023884.
66. Lutz, M. B., and G. Schuler. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23: 445-449.
67. Dhodapkar, M. V., R. M. Steinman, J. Krasovsky, C. Munz, and N. Bhardwaj. 2001. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193: 233-238.
68. Menges, M., S. Rössner, C. Voigtländer, H. Schindler, N. A. Kukutsch, C. Bogdan, K. Erb, G. Schuler, and M. B. Lutz. 2002. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195: 15-21.
69. Tenorio, A. R., J. Martinson, D. Pollard, L. Baum, and A. Landay. 2008. The relationship of T-regulatory cell subsets to disease stage, immune activation, and pathogen-specific immunity in HIV infection. J. Acquir. Immune Defic. Syndr. 48: 577-580.
70. Rosenberg, E. S., J. M. Billingsley, A. M. Caliendo, S. L. Boswell, P. E. Sax, S. A. Kalams, and B. D. Walker. 1997. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278: 1447-1450.
71. Cozzi Lepri, A., T. L. Katzenstein, H. Ullum, A. N. Phillips, P. Skinhøj, J. Gerstoft, and B. K. Pedersen. 1998. The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection. AIDS 12: 1639-1643.
72. Geskus, R. B., M. Prins, J.-B. Hubert, F. Miedema, B. Berkhout, C. Rouzioux, J.-F. Delfraissy, and L. Meyer. 2007. The HIV RNA setpoint theory revisited. Retrovirology 4: 65.
73. Hogan, C. M., V. Degruttola, X. Sun, S. A. Fiscus, C. Del Rio, C. B. Hare, M. Markowitz, E. Connick, B. Macatangay, K. T. Tashima, and B. Kallungal. 2012. The setpoint study (ACTG A5217): effect of immediate versus deferred anti-retroviral therapy on virologic set point in recently HIV-1-infected individuals. J. Infect. Dis. 205: 87-96.